$GTBIF

Green Thumb Industries (GTBIF) faces delays in marijuana rescheduling, which could ease its federal tax burden. Despite this, the company reported Q2 2026 revenue of $306.7M, EBITDA of $84.3M, and net income of $4.9M. The stock trades at $6.40, with a market cap of $1.4B. The company is using buybacks to reduce shares outstanding, but risks include pricing pressure and regulatory uncertainty.

Green Thumb Industries (GTBIF) reported Q2 revenue of $306.7M, EBITDA of $84.3M, and net income of $4.9M. The company grew revenue by 4.6% YoY and maintains a strong balance sheet with $283.6M in cash and $283M in debt. It repurchased 7.9M shares in Q2. Despite challenges, its financial flexibility and potential federal reform make it a notable player in the cannabis industry.

Green Thumb Industries (GTBIF) reported a 1.1% drop in comparable-store sales and a 4.9% decline in gross margin for Q2, with EBITDA falling to $53.1M from $69.1M. Revenue rose 4.6% to $306.7M. The company sees potential growth in Virginia and Texas, while benefiting from federal tax relief. It repurchased 7.9M shares at $6.11 each, with $283.6M in cash and $283M in debt.

Green Thumb Industries (GTBIF) reported that director Ethan Nadelmann received a grant of 5,802 Subordinate Voting Shares on September 1, 2026, at $0.00 per share, increasing his direct holdings to 74,111 shares. No Rule 10b5-1 trading plan was reported for this award.

Green Thumb Industries (GTBIF) director Jeffrey H. Goldman received a grant of 7,460 shares on September 1, 2026, increasing his direct and indirect holdings. He now holds 1,429,521 shares directly and 340,000+ indirectly through family trusts. The grant had a reported price of $0.00 per share and was not part of a Rule 10b5-1 trading plan.

Green Thumb Industries (GTII) reported Q2 2026 revenue of $306.7M, up 4.6% YoY, with a gross margin of 45.0% (down from 49.9%). The company posted net income of $4.9M, adjusted earnings of $84.3M, and operating cash flow of $29.0M. GTII maintains a strong cash position of $283.6M, distinguishing itself in the cannabis sector.

Green Thumb Industries (GTBIF) shares have fallen 5% YTD, but analysts remain bullish with a $16 avg. price target. The company reported Q2 revenue of $307M (+4.6% YoY) and net income of $4.9M. It has strong fundamentals, operational catalysts, and unique brands driving revenue. Analysts cite its strong balance sheet, share buybacks, and potential benefits from cannabis rescheduling.

Cresco Labs, Green Thumb, Curaleaf, and Verano face class-action lawsuits and RICO claims over marketing practices. Palomar Insurance seeks to deny coverage for these claims. MMJ International Holdings, a private company, highlights the regulatory and liability risks in the cannabis industry.

Curaleaf (CURLF) has proposed a $260M takeover of Aurora Cannabis (ACB), offering 0.3463 shares and $0.75 cash per share. Aurora, despite financial struggles, is attractive for its European market share. Green Thumb Industries (GTBIF), a profitable U.S. cannabis retailer, may also pursue acquisitions post-rescheduling, focusing on smaller, strategic deals.

Simply Wall St reports Green Thumb Industries’ Q2 2026 results: sales of US$306.68 million and net income of US$4.88 million, with six-month sales of US$606.87 million and net income of US$20.28 million. The company also completed a US$87.74 million buyback of 14,930,662 shares (6.54% of the share base).